- Home
- COEP vs JSPR Comparison
COEP vs JSPR Comparison
Compare COEP & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- JSPR
- Stock Information
- Founded
- COEP 2017
- JSPR 2018
- Country
- COEP United States
- JSPR United States
- Employees
- COEP N/A
- JSPR N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COEP Health Care
- JSPR Health Care
- Exchange
- COEP Nasdaq
- JSPR Nasdaq
- Market Cap
- COEP 72.1M
- JSPR 68.4M
- IPO Year
- COEP N/A
- JSPR N/A
- Fundamental
- Price
- COEP $14.79
- JSPR $1.87
- Analyst Decision
- COEP
- JSPR Buy
- Analyst Count
- COEP 0
- JSPR 11
- Target Price
- COEP N/A
- JSPR $28.00
- AVG Volume (30 Days)
- COEP 34.6K
- JSPR 372.0K
- Earning Date
- COEP 11-10-2025
- JSPR 11-07-2025
- Dividend Yield
- COEP N/A
- JSPR N/A
- EPS Growth
- COEP N/A
- JSPR N/A
- EPS
- COEP N/A
- JSPR N/A
- Revenue
- COEP $263,555.00
- JSPR N/A
- Revenue This Year
- COEP N/A
- JSPR N/A
- Revenue Next Year
- COEP N/A
- JSPR N/A
- P/E Ratio
- COEP N/A
- JSPR N/A
- Revenue Growth
- COEP N/A
- JSPR N/A
- 52 Week Low
- COEP $2.31
- JSPR $1.80
- 52 Week High
- COEP $19.19
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- COEP 46.31
- JSPR 31.58
- Support Level
- COEP $14.50
- JSPR $1.80
- Resistance Level
- COEP $15.49
- JSPR $2.51
- Average True Range (ATR)
- COEP 0.73
- JSPR 0.17
- MACD
- COEP -0.10
- JSPR -0.05
- Stochastic Oscillator
- COEP 14.91
- JSPR 10.11
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.